Isolation, Structure Determination, In Vivo/Vitro Assay and Docking Study of a Xanthone with antitumor activity from Fungus Penicillium oxalicum

Records of Natural Products

Volumn 9, Issue 2, 2015, Pages 184-189

  Chen, Gang ^a   Jiang, Zhe ^b   Bai, Jiao ^a   Wang, Haifeng ^a   Zhang, Shuling ^c   Pei, Yuehu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b YANBIAN UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor; Docking; Xanthone

Indexed keywords

2 (4 HYDROXYBENZYL)QUINAZOLIN 4(3H)ONE; ALCOHOL; ARGININE; ASPARTIC ACID; DNA TOPOISOMERASE; FLUOROURACIL; LYSINE; NATURAL PRODUCT; OXAZEPAM; PENIPANOID C; SECALONIC ACID D; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; CANCER CELL LINE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG EFFICACY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; FERMENTATION MEDIUM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYDROGEN BOND; IC50; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DOCKING; MOUSE; NONHUMAN; PENICILLIUM OXALICUM; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID TUMOR;

FUNGI; PENICILLIUM OXALICUM;

EID: 84919914061     PISSN: None     EISSN: 13076167     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. H. Ren, L. Tian, Q. Gu and W. Zhu (2006). Secalonic acid D; A cytotoxic constituent from marine lichenderived fungus Gliocladium sp. T31, Arch Pharm Res. 29, 59-63.
2. C. Ma, Y. Li, S, Niu, H. Zhang, X Liu and Y. Chen (2011). N-Hydroxypyridones, phenylhydrazones and a quinazolinone from Isaria farinose, J. Nat. Prod. 74, 32-37.
3. Y. Li, X.f. Li, D.S. Kim, H.D. Choi and B.W. Son (2003). Indolyl alkaloid derivatives, Nb-Acetyltryptamine and oxaline from a marine-derived fungus, Arch. Pharm. Res. 26, 21-23.
4. C.S. Li, C.Y. An, X.M. Li, S.S. Gao, C.M. Cui, H.F. Sun and B.G. Wang (2011). Triazole and dihydroimidazole alkaloids from the marine sediment-derived fungus Penicillium paneum SD-44, J. Nat. Prod. 74, 1331-1334.
5. H. Ren (2011). Secalonic acid D as a novel DNA topoisomerase I inhibitor from marine lichen-derived fungus Gliocladium sp. T31, Pharmaceu. Bio. 49, 796-799.
6. G. Chen, N. Xu, Z. F. Li, Q.H. Zhang, H.H. Wu and Y.H. Pei (2010). Steroidal glycosides with anti-tumor activity from the roots of Cynanchum wallichii Wight, J. Asi. Nat. Prod. Res. 12, 453-457.
7. L. Stewart, M. R. Redinbo, X. Qiu, W. G. J. Hol and J. J. Champoux (1998). A model for the mechanism of human topoisomerase I, Science. 279, 1534-1540.
8. J. J. Champoux (1981). DNA is linked to the rat liver DNA nicking-closing enzyme by a phosphodiester bond to tyrosine, J. Bio. Chem. 256, 4805-4809.
9. H. Interthal, P. M. Quigley, W. G. Hol and J. J. Champoux (2004). The role of lysine 532 in the catalytic mechanism of human topoisomerase I, J. Biol. Chem. 279, 2984-2992.
10. M. R. Redinbo, L. Stewart, P. Kuhn, J. J. Champoux and W. G. Hol (1998). Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA, Science. 279, 1504-1513.
11. F. M. Bar, M. A. Khanfar, A. Y. Elnagar, H. Liu, A. M. Zaghloul, F. A. Badria, P. W. Sylvester, K. F. Ahmad, K. P. Raisch and K. A. E. Sayed (2009). Rational design and semisynthesis of betulinic acid analogues as potent topoisomerase inhibitors, J. Nat. Prod. 72, 1643-1650.